Global Markets Direct weitere Marktdaten und Marktanalysen

Marktstudien Sprach-Filter: Deutsch Englisch Spanisch angezeigte Produkte: 1 bis 50 (von 16508 insgesamt) Jahr Preis** netto     Ireland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Ireland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Irela 2012 2.500,00$    Greece Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Greece Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Greece 2012 2.500,00$    Hungary Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Hungary Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Hunga 2012 2.500,00$    Poland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Poland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Poland 2012 2.500,00$    Portugal Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Portugal Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Port 2012 2.500,00$    Switzerland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Switzerland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the S 2012 2.500,00$    Turkey Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Turkey Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Turkey 2012 2.500,00$    Egypt Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Egypt Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Egypt W 2012 2.500,00$    United Arab Emirates Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”United Arab Emirates Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data 2012 2.500,00$    Finland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Finland Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Finla 2012 2.500,00$    Norway Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Norway Wound Care Management Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Norway 2012 2.500,00$    Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Ireland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Irelan 2012 2.500,00$    Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Greece In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Greece 2012 2.500,00$    Hungary In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Hungary In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Hungar 2012 2.500,00$    Poland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Poland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Poland 2012 2.500,00$    Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Portugal In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Portu 2012 2.500,00$    Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Switzerland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Sw 2012 2.500,00$    Turkey In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Turkey In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Turkey 2012 2.500,00$    Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Egypt In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Egypt In 2012 2.500,00$    United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”United Arab Emirates In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data 2012 2.500,00$    Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Chile In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Chile In 2012 2.500,00$    Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Finland In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Finlan 2012 2.500,00$    Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017 Global Markets Direct Global Markets Direct   Introduction ”Norway In Vitro Diagnostics Investment Opportunities, Analysis and Forecasts to 2017”, a new report by Global Markets Direct, provides key market data on the Norway 2012 2.500,00$    Breast Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Breast Cancer - Pipeline Review, H1 2012', provides an overview of the Breast Cancer therapeutic pipeline. This report provides information 2012 500,00$    Solid Tumor – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Solid Tumor - Pipeline Review, H1 2012', provides an overview of the Solid Tumor therapeutic pipeline. This report provides information on t 2012 500,00$    Lymphoma – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Lymphoma - Pipeline Review, H1 2012', provides an overview of the Lymphoma therapeutic pipeline. This report provides information on the the 2012 500,00$    Multiple Myeloma (Kahler's Disease) – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Multiple Myeloma (Kahler's Disease) - Pipeline Review, H1 2012', provides an overview of the Multiple Myeloma (Kahler's Disease) therapeutic 2012 500,00$    Ovarian Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Ovarian Cancer - Pipeline Review, H1 2012', provides an overview of the Ovarian Cancer therapeutic pipeline. This report provides informatio 2012 500,00$    Leukemias – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Leukemias - Pipeline Review, H1 2012', provides an overview of the Leukemias therapeutic pipeline. This report provides information on the t 2012 500,00$    Myelodysplastic Syndrome – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Myelodysplastic Syndrome - Pipeline Review, H1 2012', provides an overview of the Myelodysplastic Syndrome therapeutic pipeline. This report 2012 500,00$    Metastatic Breast Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Metastatic Breast Cancer - Pipeline Review, H1 2012', provides an overview of the Metastatic Breast Cancer therapeutic pipeline. This report 2012 500,00$    Brain Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Brain Cancer - Pipeline Review, H1 2012', provides an overview of the Brain Cancer therapeutic pipeline. This report provides information on 2012 500,00$    Lung Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Lung Cancer - Pipeline Review, H1 2012', provides an overview of the Lung Cancer therapeutic pipeline. This report provides information on t 2012 500,00$    Sarcomas – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Sarcomas - Pipeline Review, H1 2012', provides an overview of the Sarcomas therapeutic pipeline. This report provides information on the the 2012 500,00$    Kidney Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Kidney Cancer - Pipeline Review, H1 2012', provides an overview of the Kidney Cancer therapeutic pipeline. This report provides information 2012 500,00$    Esophageal Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Esophageal Cancer - Pipeline Review, H1 2012', provides an overview of the Esophageal Cancer therapeutic pipeline. This report provides info 2012 500,00$    Metastatic Melanoma – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Metastatic Melanoma - Pipeline Review, H1 2012', provides an overview of the Metastatic Melanoma therapeutic pipeline. This report provides 2012 500,00$    Small-Cell Lung Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Small-Cell Lung Cancer - Pipeline Review, H1 2012', provides an overview of the Small-Cell Lung Cancer therapeutic pipeline. This report pro 2012 500,00$    Glioblastoma Multiforme (GBM) – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Glioblastoma Multiforme (GBM) - Pipeline Review, H1 2012', provides an overview of the Glioblastoma Multiforme (GBM) therapeutic pipeline. T 2012 500,00$    Liver Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Liver Cancer - Pipeline Review, H1 2012', provides an overview of the Liver Cancer therapeutic pipeline. This report provides information on 2012 500,00$    Colon Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Colon Cancer - Pipeline Review, H1 2012', provides an overview of the Colon Cancer therapeutic pipeline. This report provides information on 2012 500,00$    Hodgkin Lymphoma – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Hodgkin Lymphoma - Pipeline Review, H1 2012', provides an overview of the Hodgkin Lymphoma therapeutic pipeline. This report provides inform 2012 500,00$    Substance (Drug) Abuse – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Substance (Drug) Abuse - Pipeline Review, H1 2012', provides an overview of the Substance (Drug) Abuse therapeutic pipeline. This report pro 2012 500,00$    Metastatic Pancreatic Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Metastatic Pancreatic Cancer - Pipeline Review, H1 2012', provides an overview of the Metastatic Pancreatic Cancer therapeutic pipeline. Thi 2012 500,00$    Hepatocellular Carcinoma – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Hepatocellular Carcinoma - Pipeline Review, H1 2012', provides an overview of the Hepatocellular Carcinoma therapeutic pipeline. This report 2012 500,00$    Diffuse Large B-Cell Lymphoma – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Diffuse Large B-Cell Lymphoma - Pipeline Review, H1 2012', provides an overview of the Diffuse Large B-Cell Lymphoma therapeutic pipeline. T 2012 500,00$    Renal Cell Carcinoma – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Renal Cell Carcinoma - Pipeline Review, H1 2012', provides an overview of the Renal Cell Carcinoma therapeutic pipeline. This report provide 2012 500,00$    B-Cell Lymphomas – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'B-Cell Lymphomas - Pipeline Review, H1 2012', provides an overview of the B-Cell Lymphomas therapeutic pipeline. This report provides inform 2012 500,00$    Fallopian Tube Cancer – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Fallopian Tube Cancer - Pipeline Review, H1 2012', provides an overview of the Fallopian Tube Cancer therapeutic pipeline. This report provi 2012 500,00$    Glioma – Pipeline Review, H1 2012 Global Markets Direct Global Markets Direct   Introduction Global Markets Direct’s, 'Glioma - Pipeline Review, H1 2012', provides an overview of the Glioma therapeutic pipeline. This report provides information on the therape 2012 500,00$   angezeigte Produkte: 1 bis 50 (von 16508 insgesamt) Seiten: 1  2  3  4  5  6  7  8  9  10 ...  [nächste >>]  1  11 16 21 26 31 36 41 46 51 56